pamidronate has been researched along with Carcinoma, Transitional Cell in 2 studies
Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 65-year-old woman admitted for palliative care of metastatic renal/bladder carcinoma developed symptomatic hypocalcemia nine days following a single dose of pamidronate." | 7.69 | Symptomatic hypocalcemia after intravenous pamidronate. ( Bruera, E; McIntyre, E, 1996) |
| "A 65-year-old woman admitted for palliative care of metastatic renal/bladder carcinoma developed symptomatic hypocalcemia nine days following a single dose of pamidronate." | 3.69 | Symptomatic hypocalcemia after intravenous pamidronate. ( Bruera, E; McIntyre, E, 1996) |
| "For patients with HCM who do not achieve a response from bisphosphonates, or for those who need repeated dosing more often than expected, changing to a different drug class could be an alternative." | 1.35 | A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm. ( Linneman, T; McMahan, J, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McMahan, J | 1 |
| Linneman, T | 1 |
| McIntyre, E | 1 |
| Bruera, E | 1 |
2 other studies available for pamidronate and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.
Topics: Aged; Algorithms; Bone Density Conservation Agents; Calcitonin; Carcinoma, Transitional Cell; Crysta | 2009 |
Symptomatic hypocalcemia after intravenous pamidronate.
Topics: Aged; Alberta; Carcinoma, Transitional Cell; Diphosphonates; Female; Humans; Hypercalcemia; Hypocalc | 1996 |